These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 32511751)
1. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids. Carbone F; Montecucco F; Twickler M Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751 [No Abstract] [Full Text] [Related]
2. COVID-19 coagulopathy vs disseminated intravascular coagulation. Levi M Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369 [No Abstract] [Full Text] [Related]
3. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection. Pooni RS Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158 [No Abstract] [Full Text] [Related]
4. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both. Levi M; Thachil J Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589 [No Abstract] [Full Text] [Related]
5. Coagulation abnormalities and thrombosis in patients with COVID-19. Levi M; Thachil J; Iba T; Levy JH Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672 [No Abstract] [Full Text] [Related]
6. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. Ahmed SI; Khan S Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535 [TBL] [Abstract][Full Text] [Related]
7. VTE in ICU Patients With COVID-19. Moll M; Zon RL; Sylvester KW; Chen EC; Cheng V; Connell NT; Fredenburgh LE; Baron RM; Cho MH; Woolley AE; Connors JM Chest; 2020 Nov; 158(5):2130-2135. PubMed ID: 32710891 [No Abstract] [Full Text] [Related]
8. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926 [No Abstract] [Full Text] [Related]
9. Venous thromboembolism and COVID-19. Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397 [No Abstract] [Full Text] [Related]
11. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role. Magro G Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809 [No Abstract] [Full Text] [Related]
12. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577 [TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far? Tal S; Spectre G; Kornowski R; Perl L Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 and SIC (!). Nevzorov I; Tulamo R; Albäck A; Lassila R J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749 [No Abstract] [Full Text] [Related]
18. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843 [No Abstract] [Full Text] [Related]